Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sarkany

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
BMJ Open|July 20, 2019
Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPANDJessica Walburn, Sam Norton, Robert Sarkany, et al.
The British Journal of Dermatology|October 14, 2024
A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trialJessica Walburn, Sam Norton, Robert Sarkany, et al.
Contact Dermatitis|March 21, 2013
Photopatch testing: recommendations for a European photopatch test baseline seriesMargarida Gonçalo, James Ferguson, Annie Bonevalle, et al.
American Journal of Human Genetics|April 30, 2013
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemiaKazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, et al.
The Journal of Investigative Dermatology|July 24, 2024
Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin CompactionSara Giovannini, Lisa Weibel, Birgit Schittek, et al.
Cell Reports|May 28, 2024
Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell systemCherif Badja, Sophie Momen, Gene Ching Chiek Koh, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
BMJ Open|July 20, 2019
Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPANDJessica Walburn, Sam Norton, Robert Sarkany, et al.
The British Journal of Dermatology|October 14, 2024
A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trialJessica Walburn, Sam Norton, Robert Sarkany, et al.
Contact Dermatitis|March 21, 2013
Photopatch testing: recommendations for a European photopatch test baseline seriesMargarida Gonçalo, James Ferguson, Annie Bonevalle, et al.
American Journal of Human Genetics|April 30, 2013
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemiaKazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, et al.
The Journal of Investigative Dermatology|July 24, 2024
Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin CompactionSara Giovannini, Lisa Weibel, Birgit Schittek, et al.
Cell Reports|May 28, 2024
Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell systemCherif Badja, Sophie Momen, Gene Ching Chiek Koh, et al.
The New England Journal of Medicine|November 10, 2021
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report, Damian Smedley, Katherine R Smith, et al.
Pageof 3